On May 12, 2015, a reply to objections and responses filed with respect to the plan of liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1310 and is described on the court’s official docket as follows:
Reply Plan Proponents’ Reply Memorandum of Law (i) in Response to “Objection” to Confirmation of the First Amended Joint Chapter 11 Plan of Debtor New England Compounding Pharmacy, Inc., and (ii) in Further Support of Confirmation Thereof with certificate of service filed by Creditor Committee Official Committee of Unsecured Creditors Re:  Notice of Filing of the First Amended  Joint Chapter 11 Plan of New England Compounding Pharmacy, Inc. filed by Trustee Paul D. Moore (Attachments: # 1 Exhibit A # 2 Exhibit B) (Johnson, Stephen). Related document(s)  Chapter 11 Plan filed by Creditor Committee Official Committee of Unsecured Creditors. (Baldiga, William)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.